ZUP1 and Parkinson disease: Currently, research on E3 ligase and DUB inhibitors for PD predominantly focuses on putative targets and primarily conducts fundamental investigations, with a dearth of clinical trials and applications pertaining to E3 ligase and DUB inhibitors.